CMS issues final rule blocking Medicaid funding for transgender healthcare for minors and limits CHIP coverage for such care

The Trump administration, through the Centers for Medicare and Medicaid Services, finalized a rule that restricts how states can use federal funding for transgender healthcare for minors under both Medicaid and the Children’s Health Insurance Program. CMS released the final rule on Tuesday, according to The Hill, setting federal payment limits for gender-affirming procedures involving minors financed through Medicaid and CHIP.

Under the CMS final rule described by The Hill, federal Medicaid dollars may not be used for transgender healthcare for minors. The rule also bars CHIP plans from paying for gender-affirming procedures for minors using CHIP funds. The action is framed as a federal reimbursement restriction aimed at limiting what federal dollars can cover for minors’ gender-affirming care.

Medicaid and CHIP are jointly financed health programs in which the federal government sets broad requirements for eligible coverage, benefits, and permissible use of federal dollars, while states administer programs under approved state plans and federal guidance. By issuing a final rule, CMS is using federal agency authority to define, for participating programs, which categories of care may be reimbursed when supported by Medicaid or CHIP funding for minors.

CHIP coverage is delivered through plans and coverage arrangements authorized under state programs, with federal rules governing how CHIP funds can be used. The final rule described by The Hill would therefore require state CHIP programs and associated plan administrators to adjust coverage and reimbursement practices for gender-affirming procedures for minors to remain eligible for federal CHIP funding.

The CMS final rule is an administrative step that can affect both coverage decisions at the state level and billing practices for providers serving children covered by Medicaid and CHIP. States generally need to align their Medicaid and CHIP programs with the federal terms governing permissible federal expenditures once rules take effect, through changes to coverage policies, provider guidance, and reimbursement systems.

The Hill reported the rule as “final,” which means CMS has completed the agency’s finalization process for the regulation. As with other Medicaid and CHIP rulemakings, implementation timing and compliance expectations typically depend on the rule’s effective date and any CMS transition or guidance that accompanies the regulation.

The final rule is likely to be a focal point for oversight and legal scrutiny because it directly affects a covered health-care area for minors and ties the availability of federal dollars to specific clinical categories. The Hill’s reporting did not specify any litigation or court posture at the time of publication, and the practical impacts will depend on how states implement the funding restrictions and how CMS administers compliance requirements.